XML 32 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note M - Share-based Compensation
3 Months Ended
Jun. 24, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE M– SHARE-BASED COMPENSATION
 
Total share-based compensation during the
thirteen
-week periods ended
June 24, 2018
and
June 25, 2017
was
$81,000
and
$99,000,
respectively. Total share-based compensation is included in general and administrative expenses in our accompanying Consolidated Statements of Earnings. As of
June 24, 2018,
there was
$19,000
of unamortized compensation expenses related to share-based incentive awards. We expect to recognize this expense over approximately
two
months, which represents the weighted average remaining requisite service periods for such awards.
 
The Company recognizes compensation cost for unvested stock-based incentive awards on a straight-line basis over the requisite service period. Compensation cost charged to expense under all stock-based incentive awards is as follows (in thousands):
 
    Thirteen weeks ended  
   
June 24, 2018
   
June 25, 2017
 
                 
Stock options
 
$
38
    $
38
 
Restricted stock
 
 
43
     
61
 
Total compensation cost
 
$
81
    $
99
 
 
Stock options outstanding:
 
 
During the fiscal year ended
March 29, 2015,
the Company granted options to purchase
50,000
shares at an exercise price of
$53.89
per share, all of which expire
five
years from the date of grant. All such stock options vest ratably over a
four
-year period which commenced
August 6, 2015
and contained anti-dilution rights that were structured to equalize the award’s fair value before and after the modification
.
 
There were
no
new share-based awards granted during the
thirteen
week period ended
June 24, 2018.
 
In connection with the Company’s special cash dividend, paid on
January 4, 2018,
to stockholders of record as of
December 22, 2017,
the Company performed an analysis, pursuant to the anti-dilution provisions of the
2010
Stock Incentive Plan, as amended (the
“2010
Plan”), and issued replacement options to purchase
68,498
shares at an exercise price of
$33.438
for the unvested stock options outstanding as of the record date of
December 22, 2017,
canceling
64,384
shares at an exercise price of
$35.58
per share. Nathan’s performed its evaluation based on the closing price of its common stock on
December 20, 2017,
the day before the stock went ex-dividend, of
$83.20
per share, or
$78.20
per share excluding the dividend of
$5.00
per share.
No
other terms or conditions of the outstanding options were modified.
 
In connection with the Company’s special cash dividend, paid on
March 27, 2015,
to stockholders of record as of
March 20, 2015,
the Company performed an analysis, pursuant to the anti-dilution provisions of the
2010
Plan, and issued replacement options to purchase
75,745
shares at an exercise price of
$35.58
for the unvested stock options outstanding as of
March 29, 2015,
canceling
50,000
shares at an exercise price of
$53.89.
Nathan’s performed its evaluation based on the closing price of its common stock on
March 27, 2015
of
$73.56
per share, or
$48.56
per share excluding the dividend of
$25.00
per share.
No
other terms or conditions of the outstanding options were modified.
 
Transactions with respect to stock options for the
thirteen
weeks ended
June 24, 2018
are as follows:
 
           
Weighted-
   
Weighted-
   
Aggregate
 
           
Average
   
Average
   
Intrinsic
 
           
Exercise
   
Remaining
   
Value
 
   
Shares
   
Price
   
Contractual Life
   
(in thousands)
 
                                 
                                 
Options outstanding at March 25, 2018 fiscal year (A)
   
68,498
    $
33.438
     
1.36
    $
2,648
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Options outstanding at June 24, 2018
 
 
68,498
   
$
33.438
   
 
1.12
   
$
4,207
 
                                 
Options exercisable at June 24, 2018
 
 
48,348
   
$
33.438
   
 
1.12
   
$
2,969
 
 
 
A-
Represents outstanding options after giving effect to the replacement options issued in connection with the Company’s
2015
and
2017
special dividends.
 
Restricted stock:
 
 
Transactions with respect to restricted stock for the
thirteen
weeks ended
June 24, 2018
are as follows:
 
   
 
 
 
 
Weighted-
 
   
 
 
 
 
Average
 
   
 
 
 
 
Grant-date
Fair value
 
   
Shares
   
Per share
 
Unvested restricted stock at March 25, 2018
 
 
5,000
   
$
49.80
 
Granted
 
 
-
   
 
-
 
Vested
 
 
(5,000
)
 
$
49.80
 
Unvested restricted stock at June 24, 2018
 
 
-
   
$
-